newsfilter
← Latest News
GlobeNewswire·

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

  • China SXT Pharmaceutics, Inc. (NASDAQ: SXTC) announced a 1-for-150 share consolidation effective February 3, 2026.
  • Class A ordinary shares will begin trading on a post-consolidation basis at the market open on February 3, 2026, under the symbol "SXTC" with a new CUSIP number G2161P165.
  • Pre-consolidation outstanding shares totaled 143,693,892, which will be reduced to approximately 957,960 post-consolidation shares with fractional shares rounded up.
  • All outstanding stock options, warrants, & other rights to purchase Class A ordinary shares will be adjusted proportionately due to the consolidation.
  • Shareholders holding shares through brokers or nominees will have their holdings automatically adjusted & may contact Transhare Corporation at +1 303-662-1122 for questions.